Scinai Immunotherapeutics...

NASDAQ: SCNI · Real-Time Price · USD
1.57
-0.02 (-1.26%)
At close: Aug 18, 2025, 3:59 PM
1.60
1.81%
After-hours: Aug 18, 2025, 07:51 PM EDT

Scinai Immunotherapeutics Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Revenue
658K n/a n/a n/a
Cost of Revenue
1.24M 512.67K 559.8K 747.65K
Gross Profit
-580K n/a n/a n/a
Operating Income
-8.64M -9.71M -11.06M -10.87M
Interest Income
100K 122.68K 8.1M 929.00
Pretax Income
4.8M -6.5M -5.8M -8.21M
Net Income
4.8M -6.5M -5.8M -8.21M
Selling & General & Admin
2.53M 4.5M 5.3M 7.63M
Research & Development
5.53M 5.21M 5.76M 3.25M
Other Expenses
n/a -9K n/a -12K
Operating Expenses
8.06M 9.18M 11.06M 10.05M
Interest Expense
1.44M 7.98K 5.05M 3.36M
Selling & Marketing Expenses
n/a n/a n/a -91.96K
Cost & Expenses
9.3M 9.71M 11.06M 10.87M
Income Tax Expense
n/a n/a n/a n/a
Shares Outstanding (Basic)
806.37K 390.66K 188.52K 102.57K
Shares Outstanding (Diluted)
806.37K 390.66K 188.52K 141.14K
EPS (Basic)
5.95 -66.56K -122.96K -232.56K
EPS (Diluted)
5.95 -66.56K -122.96K -320K
EBITDA
7.87M -9.19M -10.5M -10.39M
EBIT
6.22M -9.71M -11.06M -10.86M
Depreciation & Amortization
1.65M 514K 562K 471K